What is the appropriate dose of injectable unfractionated heparin for deep vein thrombosis prophylaxis in a 45‑kg adult with an estimated glomerular filtration rate of 20 mL/min?

Unfractionated Heparin Dosing for DVT Prophylaxis in Severe Renal Impairment

For a 45 kg patient with GFR 20 mL/min requiring DVT prophylaxis, use unfractionated heparin 5,000 units subcutaneously every 8 hours, as UFH is the preferred agent in severe renal dysfunction and does not require dose adjustment.

Rationale for Agent Selection

Unfractionated heparin is the anticoagulant of choice in patients with creatinine clearance <30 mL/min because the liver is the main site of heparin biotransformation, unlike low-molecular-weight heparins (LMWHs) which depend on renal clearance 1. The guidelines explicitly state that LMWHs should be avoided in patients with creatinine clearance <30 mL/min or require dose adjustments based on anti-factor Xa levels 1. With a GFR of 20 mL/min, this patient falls well below this threshold, making UFH the safest option 1.

Specific Dosing Regimen

The recommended prophylactic dose is 5,000 units subcutaneously every 8 hours 1, 2. This regimen is superior to twice-daily dosing:

• Every 8-hour dosing (three times daily) is more effective than every 12-hour dosing (twice daily) for DVT prophylaxis 1
• The guidelines note that 5,000 units every 12 hours "appears to be less effective" 1
• In general medical patients, the combined endpoint of proximal DVT and PE showed significant reduction with three-times-daily dosing, though major bleeding risk was higher 1

Administration Details

• Route: Deep subcutaneous (intrafat) injection 2
• Technique: Use a fine needle (25-26 gauge) in the arm or abdomen, rotating injection sites to prevent hematoma formation 2
• Timing: Continue throughout hospitalization or until fully ambulatory 1

Weight Considerations

At 45 kg, this patient is significantly below the standard 68 kg reference weight used in dosing tables 2. However, prophylactic UFH dosing is fixed and not weight-adjusted, unlike therapeutic dosing which uses 80 units/kg bolus followed by 18 units/kg/hour 1. The 5,000 units every 8 hours regimen remains appropriate regardless of body weight for prophylaxis 2.

Monitoring Requirements

• No routine aPTT monitoring is needed for prophylactic low-dose heparin in patients with normal baseline coagulation parameters 2
• Monitor platelet count every 2-3 days up to at least day 14, then every 2 weeks or as clinically indicated to detect heparin-induced thrombocytopenia 1
• Monitor hemoglobin, hematocrit, and tests for occult blood periodically 2

Critical Safety Considerations

Contraindications to assess before initiating heparin 1:

• Recent CNS bleed or intracranial/spinal lesion at high bleeding risk
• Active major bleeding (>2 units transfused in 24 hours)
• Thrombocytopenia (platelets <50,000/mcL)
• Severe platelet dysfunction
• History of heparin-induced thrombocytopenia (absolute contraindication to UFH) 1

Why Not Alternative Agents

Fondaparinux is contraindicated in patients with creatinine clearance <30 mL/min 1. LMWHs (enoxaparin, dalteparin, tinzaparin) should be avoided as they are dependent on significant renal clearance 1. Even with dose adjustments and anti-factor Xa monitoring, the risk-benefit ratio favors UFH in this degree of renal impairment 1.

Expected Efficacy

Subcutaneous UFH at 5,000 units every 8 hours has demonstrated significant reduction in DVT and pulmonary embolism in randomized trials, with PE reduction from 20% to 5% and DVT reduction from 73% to 22% in one study 1. The regimen also showed lower 3-month mortality (21% vs 33%) compared to no prophylaxis 1.